Literature DB >> 10469323

Human herpesvirus 7 and pityriasis rosea.

T Watanabe, M Sugaya, K Nakamura, K Tamaki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469323     DOI: 10.1046/j.1523-1747.1999.00658.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

1.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

2.  The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea.

Authors:  Francesco Drago; Giulia Ciccarese; Francesco Broccolo; Massimo Ghio; Paola Contini; Hajdhica Thanasi; Aurora Parodi
Journal:  Mediators Inflamm       Date:  2015-09-10       Impact factor: 4.711

Review 3.  Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria.

Authors:  Antonio Chuh; Vijay Zawar; Michelle Law; Gabriel Sciallis
Journal:  Infect Dis Rep       Date:  2012-02-15

Review 4.  Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects.

Authors:  Khushbu Mahajan; Vineet Relhan; Aditi Kochhar Relhan; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

5.  Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in Pityriasis rosea Patients: A Pilot Study.

Authors:  Abhishek De; Subrata Roy; Soumi Sukla; Asad Ansari; Subhajit Biswas
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.